A Phase I Safety and Immunogenicity Trial of Live Recombinant Canarypox ALVAC-HIV (vCP205) in HIV-1 Uninfected Adult Volunteers
Clinical trial NCT00001055 · COMPLETED
Trial details
- NCT number
- NCT00001055
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Enrollment
- 76
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.